ABSTRACT. Nephritis characterized by IgA mesangial depositions has been described both in Henoch-Schoenlein purpura (HSP) and in Berger's disease (BD), but common genetic traits are still uncertain. We report here the case of two brothers, the first affected by HSP with persistent nephritis and the second by BD, accidentally discovered as silent microhematuria 1 year after HSP onset in the first brother. HLA genotyping demonstrated the presence of HLA-B35 in both patients. Our findings reinforce the need to screen for urinary abnormalities in family members of patients affected by HSP nephritis to identify a silent IgA nephropathy.
INTRODUCTION
Berger's disease (BD) and Henoch-Schoenlein purpura (HSP) have been shown to bear a relationship to each other, since both may be found consecutively in the same patient, in identical twins and even in family groups. Nephritis characterized by IgA mesangial deposition is observed in both forms. Common genetic traits have been progressively studied without any certain results, although the HLA genotype is frequently implicated.
MATERIAL AND METHODS
We report a family case of IgA nephropathy (IgAN) occurring in two Caucasian brothers, the first with HSP and the second with BD. We performed HLA genotyping using the Dynal SSP kit (Dynal Biotech Ltd., Wirral, UK), in search of a common genetic trait.
CASE DESCRIPTION
Patient 1: a 9-year-old boy presented at the emergency room with palpable purpura of the lower limbs after a sore throat and colicky abdominal pain without vomit or diarrhea. While abdomen ultrasound was normal, urinalysis showed hematuria (later confirmed by microscopy as glomerular hematuria, >10 red blood cells per high power field) and proteinuria (>500 mg/24 h). Throat swab was negative, excluding the role of streptococcal infection. Further onset of arthralgia of the knees and ankles supported the clinical diagnosis of HSP with cutaneous, articular and renal involvement. Despite steroid therapy, a relapse occurred 2 weeks after onset. Blood tests showed increased IgA levels (268 mg/dL) with normal C3, and urinalysis demonstrated persistent proteinuria and hematuria with no alterations in renal function or blood pressure. Because of the poor response to steroid therapy, intravenous immunoglobulin was administered with rapid improvement. One year later, given the persistence of microhematuria and proteinuria (741 mg/24 h), a renal biopsy was performed, which revealed IgA deposition in the mesangium.
Patient 2: during a routine visit, the 14-year-old brother of patient 1 showed a positive urine dipstick for hematuria. Confirmation of true isolated glomerular hematuria was obtained by urine microscopic examination (5 red blood cells per high-power field). This abnormality persisted at follow-up controls, and after an episode of upper airway infection, the patient presented at the emergency room with "tea-like" urine and back pain. Elevation of serum creatinine (1.13 mg/dL), hematuria (>10 red blood cells per high-power field) and proteinuria (>500 mg/24 h) with normal kidney ultrasound and blood pressure demonstrated a moderate renal involvement. Post-streptococcal glomerulonephritis was excluded because of increased serum IgA (326 mg/dL) with normal C3 level and negative throat swab. The patient underwent renal biopsy that showed expansion of the mesangial matrix and marked IgA depositions. Treatment with angiotensin-converting enzyme inhibitor was started due to the evidence of proteinuria.
Since the renal histological and immunofluorescence microscopy findings in the first brother were indistinguishable from those seen in the second one, genetic analysis involving HLA typing was performed. DNA was extracted from peripheral blood collected in EDTA. HLA typing (using the Dynal SSP kit) finally demonstrated the presence of HLA-B35 in both patients.
DISCUSSION
IgAN is the most common form of chronic glomerulonephritis in children and adults. Macroscopic recurrent hematuria with or without proteinuria is the typical presentation, commonly associated with upper respiratory tract infections. Silent microscopic hematuria can also be found. Normal or elevated serum IgA levels with normal serum C3 levels help to distinguish this disorder from post-streptoccocal glomerulonephritis. Clinical diagnosis is confirmed by renal biopsy, which is able to reveal polymeric IgA1 mesangial depositions with focal and segmental mesangial hypercellularity and matrix expansion, varying degrees of glomerulosclerosis and interstitial fibrosis.
IgAN showed a different clinical spectrum since it has been reported both in BD and in HSP. While the kidneys are always involved in BD, approximately 50% of patients develop acute kidney involvement in HSP, varying from asymptomatic microscopic hematuria to severe macroscopic hematuria with proteinuria and even to nephrotic syndrome (Chang et al., 2005; Jauhola et al., 2010) . Renal involvement typically occurs in the first three months after onset, more commonly with disease relapse. Renal progressive damage develops in up to 30% of children with BD (particularly in patients with proteinuria or renal failure at presentation) and in 2-5% of HSP 15-20 years after the first manifestation of disease, and therefore, a careful longterm follow-up of renal function and blood pressure is mandatory. Although there are cases of rapidly progressive forms, IgAN is an uncommon cause of end-stage renal disease in childhood.
Pathogenesis is still unclear and results from genetic association studies are inconsistent. It has been hypothesized that genetic predisposition and antigen exposure increase circulating IgA levels and disrupt IgG synthesis, predisposing to polymeric IgA deposition in systemic small vessels and glomerular vessels. This interaction between genes and environmental triggers could be confirmed by familial clustering of HSP and BD and by their development within different members of the same family (Levy, 1989; Motoyama and Iitaka, 2005; Zhang et al., 2008) . BD and HSP have been described in identical twins and may also be encountered consecutively in the same patient, evolving from HSP to BD (Lilien et al., 1996) or vice versa (Chishiki et al., 2010) . Demographic and family studies on IgAN have always focused on the major histocompatibility complex. Recently, genome-wide linkage analysis have suggested a strong linkage of IgAN to the HLA region on chromosome 6p22-23 both in family-based and case-control analyses in the UK white population, with no other association of comparable strength found across the genome (Feehally et al., 2010) .
HLA-DRB1*01 has been found associated with high risk of HSP in Italy and Spain although this antigen was not related to any particular feature of the disease phenotype (Amoroso et al., 1997; Amoli et al., 2001) . HLA-DRB1*01 allele is in linkage disequilibrium with HLA-B35, HLA-B14 and HLA-B27 in Caucasian populations. In particular, the HLA-B35 haplotype was previously described as related to an increased predisposition to HSP (Peru et al., 2008) , to HSP recurrent forms (Nathwani et al., 1992) and HSP nephritis. All these clinical features were also associated with HLA-B35 in patient 1. Only the presence of abdominal pain was in contrast to the literature, where no HLA-B antigenic associations have been observed in association with gastrointestinal manifestations (Amoli et al., 2002) .
When considering BD, the frequencies of HLA-DR4 and HLA-B35 in the Japanese population (Hiki et al., 1990) are significantly higher in BD than in controls. HLA-B35 has also been reported as a marker of severity and a poor prognostic factor since it was associated with end-stage renal failure in IgAN (Alamartine et al., 1991; Doxiadis et al., 2001) . In patient 2, we observed an increase of serum creatinine and proteinuria at disease onset, representing a risk factor for progressive renal damage.
In addition, both our patients developed clinical symptoms in association with an upper respiratory infection with negative throat swab. This type of infection could be fundamental for the development of IgA nephropathy; moreover, HLA-B35 has been reported to be associated with the severity of viral illness (Klein et al., 1994) and possibly with an augmentation in response of cytotoxic T lymphocyte to alloantigens (Burrows et al., 1997) .
In conclusion, given the common genetic and environmental trigger, we think that careful clinical monitoring should be considered in other family members, not only in BD history but also in HSP, especially when HSP is recurrent and/or develops into persistent nephritis. Silent BD nephropathy could be identified in the relatives and, if necessary, they could be promptly treated using anti-inflammatory strategies (fish oil, vitamin E), angiotensin-converting enzyme inhibitors, or steroid therapy if severe proteinuria and/or renal insufficiency is present. Early diagnosis and treatment of IgAN in children may bring about important benefits and a favorable prognosis (Bulut et al., 2012) .
To our knowledge this is the first report to highlight the association between HLA-B35 and IgAN both in HSP and BD. These results suggest a link between the two diseases and reinforce the idea of a common pathogenesis, suggesting a role of HLA-B35 in IgA mesangial deposition. We are aware that our study has a weak point, since we lost the children's parents at follow-up due to social problems, so it was impossible to construct a pedigree and eventually genotype them and other relatives to determine the incidence of HLA-B35 in the family. Moreover, since HLA-B35 was not always positive in other familial studies of IgAN (Montoliu et al., 1990) , additional studies are required to uncover other HLA-associated alleles to identify possible genetic loci in IgAN susceptibility and disease severity.
